Ocular Therapeutix: Axpaxli's Dual Trial Strategy And Blockbuster Potential

Core Insights - Ocular Therapeutix is a biotech company focused on developing treatments for retinal diseases, particularly its flagship drug candidate "Axpaxli" aimed at wet AMD [1] Company Overview - The company has been concentrating on its lead drug candidate, Axpaxli, since June 2024 [1] Product Focus - Axpaxli is specifically designed for the treatment of wet age-related macular degeneration (AMD) [1]